In 2010, a multicenter, randomized, open-label, phase III trial was conducted to assess the effect of sunitinib versus capecitabine as a treatment for advanced breast cancer patients with disease recurrence after anthracycline and taxane therapy ( Bergh et al
Companies entering the peptide market will need to go beyond current compounding requirements by clearly communicating risks, providing prominent safety and side effect warnings, implementing robust patient screening protocols, and steering consumers away from misleading peptide information circulating on social media, online forums, and unverified sellers
However, while they provide men and women with a way to supplement weight loss, they arent a forever solution
Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland
Its pros significantly outweigh the cons, especially for dedicated athletes and fitness enthusiasts